Form D · Other Technology
1200 Pharma LLC
Culver City, CA · CIK 0001723507
Offering snapshot reported Apr 30, 2024 · SEC filing
- Reported sold
- $2.33M Indefinite offering
- Investors reported
- 30 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 15, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 30, 2024 | Initial | $2,325,500 | No comparison | 30 | SEC filing |
| Dec 12, 2019 | Initial | $5,500,000 | No comparison | 5 | SEC filing |
| Nov 22, 2017 | Initial | $6,249,997 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-511898
Source: Form D, filed Apr 30, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Attanasio | Director |
| David Chang | Director |
| David Licata | Director |
| Lee Sailor | Executive |
| Dennis Slamon | Director |
| Brian Stoltz | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
6100 Bristol Parkway
Culver City, CA, 90230
Culver City, CA, 90230